Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT07535346
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 14 Years - 21 Years
- Healthy Volunteers
- Accepted
Interventions
- Health MPowerment App — BEHAVIORALA mobile health app designed to facilitate increased PrEP use and adherence among AYAs
Study Details
This study applies Social Cognitive Theory to develop behavioral interventions promoting PrEP adherence. It seeks to adapt and test the enhanced HMP app for feasibility and acceptability among Black adolescents and young adults (AYAs) and adult supports.
Key Dates
- Start date
- Aug 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: AYA groupAll enrolled participants (AYAs and support persons) will receive a demonstration of the app, including all of its features. All participants will use the app for 6 months. Each dyad of participants will be instructed to use the app to communicate with each other and AYAs will be instructed to use the app to keep track of their PrEP. Data from the medication tracker will be collected at 1-, 3-, and 6-months
Primary Outcome Measure
Acceptability/Usability [ Time Frame: 1 month, 3 months, and 6 months ]
Central Contacts
- Samantha Hill, MD, MPH404-778-1537
- Jacob Aiello, MPH404-712-9344
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory University | Atlanta | Georgia | 30322 |
Find similar trials in Atlanta, GA
By condition
By specialty
By research site
Related Studies
- HIV Treatment Adherence Dose Determination TrialRecruiting · University of Connecticut · Storrs, Connecticut
- Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in PediatricsPHASE1/PHASE2 · Recruiting · ViiV Healthcare · Long Beach, California
- Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706PHASE1 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California
- A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1PHASE3 · Recruiting · ViiV Healthcare · Birmingham, Alabama